BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24896364)

  • 1. From neurogenesis to neuroprotection in the epilepsy: signalling by erythropoietin.
    Castaneda-Arellano R; Beas-Zarate C; Feria-Velasco AI; Bitar-Alatorre EW; Rivera-Cervantes MC
    Front Biosci (Landmark Ed); 2014 Jun; 19(8):1445-55. PubMed ID: 24896364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin: a neuroprotective agent in cerebral hypoxia, neurodegeneration, and epilepsy.
    Merelli A; Czornyj L; Lazarowski A
    Curr Pharm Des; 2013; 19(38):6791-801. PubMed ID: 23530506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protecting neurons.
    Ferriero DM
    Epilepsia; 2005; 46 Suppl 7():45-51. PubMed ID: 16201995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exposure to nerve agents: from status epilepticus to neuroinflammation, brain damage, neurogenesis and epilepsy.
    de Araujo Furtado M; Rossetti F; Chanda S; Yourick D
    Neurotoxicology; 2012 Dec; 33(6):1476-1490. PubMed ID: 23000013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effects of erythropoietin on histological and functional outcomes following traumatic brain injury in rats are independent of hematocrit.
    Zhang Y; Xiong Y; Mahmood A; Meng Y; Qu C; Schallert T; Chopp M
    Brain Res; 2009 Oct; 1294():153-64. PubMed ID: 19646970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human erythropoietin protects against brain injury through blunting the mTORC1 pathway in the developing brains of rats with seizures.
    Li Q; Han Y; Du J; Jin H; Zhang J; Niu M; Qin J
    Life Sci; 2018 Feb; 194():15-25. PubMed ID: 29233655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced oligodendrogenesis and recovery of neurological function by erythropoietin after neonatal hypoxic/ischemic brain injury.
    Iwai M; Stetler RA; Xing J; Hu X; Gao Y; Zhang W; Chen J; Cao G
    Stroke; 2010 May; 41(5):1032-7. PubMed ID: 20360553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective properties and mechanisms of erythropoietin in in vitro and in vivo experimental models for hypoxia/ischemia.
    van der Kooij MA; Groenendaal F; Kavelaars A; Heijnen CJ; van Bel F
    Brain Res Rev; 2008 Nov; 59(1):22-33. PubMed ID: 18514916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic benefit of a combined strategy using erythropoietin and endothelial progenitor cells after transient focal cerebral ischemia in rats.
    Pellegrini L; Bennis Y; Guillet B; Velly L; Garrigue P; Sabatier F; Dignat-George F; Bruder N; Pisano P
    Neurol Res; 2013 Nov; 35(9):937-47. PubMed ID: 23816235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin-mediated neuroprotection in a pediatric mouse model of chronic hypoxia.
    Chung E; Kong X; Goldberg MP; Stowe AM; Raman L
    Neurosci Lett; 2015 Jun; 597():54-9. PubMed ID: 25899777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin 2nd cerebral protection after acute injuries: a double-edged sword?
    Velly L; Pellegrini L; Guillet B; Bruder N; Pisano P
    Pharmacol Ther; 2010 Dec; 128(3):445-59. PubMed ID: 20732352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective role of erythropoietin in neonates.
    Juul S
    J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 4():105-7. PubMed ID: 22958035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic strategy of erythropoietin in neurological disorders.
    Liu XB; Wang JA; Yu SP; Keogh CL; Wei L
    CNS Neurol Disord Drug Targets; 2008 Jun; 7(3):227-34. PubMed ID: 18673207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of erythropoietin in the brain.
    Noguchi CT; Asavaritikrai P; Teng R; Jia Y
    Crit Rev Oncol Hematol; 2007 Nov; 64(2):159-71. PubMed ID: 17482474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin as a novel neuroprotectant.
    Genc S; Koroglu TF; Genc K
    Restor Neurol Neurosci; 2004; 22(2):105-19. PubMed ID: 15272145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-dependent effect of combination therapy with erythropoietin and granulocyte colony-stimulating factor in a mouse model of hypoxic-ischemic brain injury.
    Yu JH; Seo JH; Lee JE; Heo JH; Cho SR
    Neurosci Bull; 2014 Feb; 30(1):107-17. PubMed ID: 24435306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed administration of erythropoietin reducing hippocampal cell loss, enhancing angiogenesis and neurogenesis, and improving functional outcome following traumatic brain injury in rats: comparison of treatment with single and triple dose.
    Xiong Y; Mahmood A; Meng Y; Zhang Y; Qu C; Schallert T; Chopp M
    J Neurosurg; 2010 Sep; 113(3):598-608. PubMed ID: 19817538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Erythropoietin and neuroprotection].
    Chatagner A; Hüppi PS; Ha-Vinh Leuchter R; Sizonenko S
    Arch Pediatr; 2010 Sep; 17 Suppl 3():S78-84. PubMed ID: 20728813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin on a tightrope: balancing neuronal and vascular protection between intrinsic and extrinsic pathways.
    Li F; Chong ZZ; Maiese K
    Neurosignals; 2004; 13(6):265-89. PubMed ID: 15627815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain protection by erythropoietin: a manifold task.
    Rabie T; Marti HH
    Physiology (Bethesda); 2008 Oct; 23():263-74. PubMed ID: 18927202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.